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To examine the roles of TGFb isoforms on corneal morphogenesis, the eyes of mice that lack TGFbs were analyzed at
different developmental stages for cell proliferation, migration and apoptosis, and for expression patterns of keratin 12,
lumican, keratocan and collagen I. Among the three Tgfb2/2 mice, only Tgfb22/2 mice have abnormal ocular morphogenesis
characterized by thin corneal stroma, absence of corneal endothelium, fusion of cornea to lens (a Peters’-like anomaly
phenotype), and accumulation of hyaline cells in vitreous. In Tgfb22/2 mice, fewer keratocytes were found in stroma that
has a decreased accumulation of ECM; for example, lumican, keratocan and collagen I were greatly diminished. The absence
of TGFb2 did not compromise cell proliferation, nor enhance apoptosis. The thinner stroma resulting from decreased ECM
synthesis may account for the decreased cell number in the stroma of Tgfb2 null mice. Keratin 12 expression was not altered
in Tgfb22/2 mice, implicating normal corneal type epithelial differentiation. Delayed appearance of macrophages in ocular
tissues was observed in Tgfb22/2 mice. Malfunctioning macrophages may account for accumulation of cell mass in vitreous
of Tgfb2 null mice. © 2001 Elsevier Science
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Corneal morphogenesis during eye development of verte-
brates involves the differentiation of cells from surface
ectoderm and the migration of mesenchymal cells of neural
crest origin (Hay, 1980). The differentiation of surface
ectoderm gives rise to corneal and conjunctival epithelia of
the ocular surface as well as glandular epithelium, for
example, lacrimal gland (Lovicu et al., 1999). The mesen-
chymal cells of neural crest origin become corneal endothe-
lial cells and keratocytes, the stromal fibroblasts (Hay,
1980). The corneal epithelium synthesizes components of
extracellular matrix (ECM) for the formation of primary
stroma when the lens detaches from the ectoderm during
ocular development. In avian corneal development, the first
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All rights reserved.wave of mesenchymal cells that migrate underneath the
primary stroma forms the endothelium (Hay, 1980). The
mesenchymal cells of the second wave of migration invade
the primary stroma and become keratocytes, which are
responsible for the formation of secondary stroma of adult
vertebrates. In contrast, during mouse embryonic develop-
ment there is only a single influx of mesenchymal cells,
which invade the primary stroma and form both the corneal
stroma and endothelium as previously reported by others
(Dublin, 1970; Haustein, 1983; Kidson et al., 1999; Pei and
Rhodin, 1971). This orderly cellular migration and differen-
tiation are controlled by cues from various cytokines and
the components of ECM, which are under constant remod-
eling during embryonic development (Hay, 1995; Hay and
Zuk, 1995; Hogan, 1994; Hogan, 1999; Tripathi et al., 1991).
For example, members of the TGFb superfamily play piv-
otal roles in embryonic development (Hay, 1995) (Hogan,
1994). However, the precise cytokines and their functions
that modulate corneal morphogenesis remain unknown. It
is very likely that cytokine signaling may modulate the
expression of specific transcription factors that contribute
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or vise versa.
Recently, mutations of the transcription factor gene
FKLH 7 in human and ablation of FoxC1 (formerly known
as Mf 1) and Pitx2 in mice have been linked to Axenfeld-
Reiger’s and Peters’ anomaly (Kidson et al., 1999; Lu et al.,
1999). The molecular and cellular mechanisms that cause
the anomaly by mutations of FoxC1 and Pitx2 remain
unknown. Clinically, Axenfeld-Reiger’s anomaly differs
from Peters’ anomaly in that the former is characteristic of
partial fusion of iris to corneal endothelium and usually
with transparent cornea stroma, whereas the latter repre-
sents a more severe phenotype in which lens fuses to cornea
where the endothelium is missing and is frequently associ-
ated with corneal cloudiness (Waring et al., 1982; Waring
and Parks, 1977). It had been suggested that both Axenfeld-
Reiger’s and Peters’ anomaly were related to defects in the
maturation of mesenchymal cells of neural crest origin
during embryonic development. However, there is limited
information available to indicate that mutation and/or
ablations of specific cytokines may lead to abnormal cor-
neal morphogenesis similar to what has been found in
Axenfeld-Reiger’s and Peters’ anomaly. Sanford et al. re-
cently demonstrated that the Tgfb22/2 mice had very thin
corneas (Sanford et al., 1997), but it is not known the degree
to which this defect resembles either Axenfeld-Reiger’s or
Peters’ anomaly.
In the present studies we elucidate the roles of TGFb
isoforms in corneal morphogenesis and further examine
corneal morphogenesis among Tgfb12/2, Tgfb22/2, and
Tgfb32/2 mice by light and electron microscopy and by
expression of differentiation markers of corneal cells, for
example, keratin 12, collagen IV, tubedown protein (TBDN-
1), N-cadherin, and keratocan. Our results indicate that
only Tgfb22/2 mice are characterized by abnormal eye
development. In Tgfb22/2 mice the fusion of cornea to lens
capsule results in the failure of anterior chamber formation.
The loss of TGFb2 does not lead to a significant alteration
of the expression levels of many differentiation markers, for
example, collagen IV, keratin 12 in epithelium. However,
the synthesis of ECM components by keratocytes is greatly
diminished in Tgfb2 null mice. Thus, Tgfb22/2 mice mani-
fest Peters’-like anomaly.
MATERIALS AND METHODS
Preparation of Tgfb2 Null Mouse Embryos
Tgfb2 null mice were generated via gene targeting as previously
reported. Homozygous mice could not survive longer than 2 h
because of impaired cardiovascular function whereas, heterozygous
mice presented no apparent defects. Cesarean-derived embryos at
various developmental stages (E12.5, 14.5, 15.5, 16.5, and 18.5)
were genotyped by polymerase chain reaction (PCR) as previously
reported (Sanford et al., 1997). Some of the embryos were labeled
with BrdU as descried below (Szerenyi et al., 1994). The embryos
were fixed with 4.0% paraformaldehyde in 0.1M phosphate buffer
for 48 h, dehydrated, embedded in paraffin and processed for
© 2001 Elsevier Science. Ahistological examination. The numbers of litters examined for light
microscopic histology including those labeled with BrdU were 6, 4,
2, 4, and 5 at E12.4, 14.5, 15.5, 16.5, and 18.5, respectively. And the
numbers of the heterozygous and homozygous embryos were 15
and 7 (E12.5), 11 and 7 (E14.5), 9 and 6 (E15.5), 11 and 7 (E16.5), and
11 and 8 (E18.5), respectively. The numbers of litters of Tgfb2
knockout embryos processed for BrdU labeling were 5, 2, 1, 2, and
2 at E12.5, 14.5, 15.5, 16.5, and 18.5, respectively. The numbers of
the heterozygous and homozygous embryos were 12 and 5 (E12.5),
8 and 3 (E14.5), 6 and 3 (E15.5), 7 and 3 (E16.5), and 4 and 4 (E18.5),
respectively.
Tgfb1 and Tgfb3 Null Mouse Embryos at E18.5
Mice heterozygous for the Tgfb1 or Tgfb3 null allele have been
generated via gene targeting. Cesarean-derived littermates of E18.5
embryos were genotyped by PCR as previously reported (Proetzel et
al., 1995; Shull and Doetschman, 1994). Each embryo was labeled
with BrdU as described below. Littermates that were heterozygous
and homozygous for the Tgfb1 and Tgfb3 null allele were processed
for histological examination. The numbers of litters of Tgfb1 and
Tgfb3 knockout mice that had been processed for histology were 2
and 1, respectively, and the numbers of heterozygous and homozy-
gous embryos were 6 and 5, and 4 and 1 for TGFb1- and b3-deficient
mice, respectively.
Histology and Immunohistochemistry
Histology of the eyes of the embryos was examined by light
microscopy after hematoxylin and eosin staining or Masson’s
trichrome staining. To locate types I and IV collagen, lumican and
keratin 12 proteins, 5 mm paraffin sections were deparaffinized,
blocked and processed for indirect immunostaining using rabbit
polyclonal anti-type I collagen and rabbit anti-type IV collagen
antibodies (Southern Biotechnologies, Inc., Birmingham, AL, USA),
and epitope-specific rabbit antibodies against synthetic mouse
lumican and mouse keratin 12 peptides as primary antibodies, and
peroxidase-conjugated antibodies were used as secondary antibod-
ies (Southern Biotechnologies) as previously reported (Ishizaki et
al., 1997; Kao et al., 1996; Saika et al., 2000). For type IV collagen
and macrophage [F4/80 monoclonal antibodies (Austyn and Gor-
don, 1981)] immunostaining, deparaffinized sections were treated
with 10 mg/ml trypsin (Sigma) for 20 min at 37°C to unmask the
antigenic epitope (Ishizaki et al., 1997). Antibody reaction was
visualized with 3, 39-diaminobenzidine. The specimens were coun-
terstained with hematoxylin, dehydrated through a graded ethanol
series, mounted in balsam, and observed by light microscopy.
TBDN-1 and N-cadherin Immunocytochemistry
Immunocytochemistry was performed on paraformaldehyde
fixed, paraffin embedded sections of mouse embryo tissues to
detect TBDN-1 expression as previously described (Gendron et al.,
2000) and N-cadherin expression using the 13A9 anti-N-cadherin
mouse monoclonal antibody (Transduction Laboratories, Lexing-
ton, KY, USA). Following a 1 h blocking step in 6% low fat milk in
0.15 M NaCl, 10 mM Tris–HCl buffer, pH 7.4 (TBS), sections were
incubated with either a 1/100 dilution of chicken anti-TBDN-1 IgY
Ab1272, an equal concentration of preimmune IgY or a 1/500
dilution of anti-N-cadherin. After rinsing in TBS, reactions were
developed using biotinylated secondary antibodies and alkaline
phosphatase-conjugated avidin reagent (Vector Laboratories). Red
ll rights reserved.
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in the presence of Fast Red and Levamisole (to block endogenous
tissue alkaline phosphatase activity). Substrate development times
were 20 min. Slides were not counterstained. Sections were then
dried and mounted in permount (Fisher Scientific, Pittsburgh, PA,
USA), viewed and photographed.
Transmission Electron Microscopy
Both eyes of one litter of E18.5 embryos (3 wild type, 3 heterozy-
gous, and 2 homozygous) of a Tgfb21/2 cross were fixed with 2.5%
glutaraldehyde in 0.1 M phosphate buffer and then post fixed with
2.0% osmium tetraoxide for 2 h. The specimens were dehydrated
and embedded in Epon 812 mixture. Ultrathin sections were
stained with electron dense uranyl acetate and lead citrate and
observed under transmission electron microscopy (Saika et al.,
1999). Corneas, anterior lens capsules and lens epithelial cells were
examined.
In Situ Hybridization for mRNAs of ECM
Components
To study the expression patterns of ECM components in devel-
oping mouse eyes, in situ hybridization using riboprobes was
performed. Five micrometers thick paraffin sections were deparaf-
finized and processed for in situ hybridization with riboprobes of
mouse lumican, keratocan, and keratin12 as previously reported
(Kao et al., 1996; Liu et al., 1998; Saika et al., 2000). Briefly, the
plasmid DNAs of mouse lumican, keratocan, and keratin 12 were
linearized; T-7 and T-3 RNA polymerases were used to synthesize
digoxigenin-conjugated antisense and sense riboprobes, respec-
tively (Ambione, Austin, TX, USA). After hybridization at 45°C
overnight the sections were subjected to stringent washes. Ribo-
probes nonspecifically bound were removed by RNase digestion.
The sections were then treated with an alkaline phosphatase-
conjugated anti-digoxigenin antibody (Boehringer Mannheim, Indi-
anapolis, IN, USA). Hybridization signals were visualized with
4-nitroblue tetrazolium chloride. The sections were dehydrated,
mounted and observed under light microscopy after 0.5% neutral
red counterstaining.
Northern Hybridization for mRNAs of ECM
Components from E18.5 Whole Eyes of TGFb-
deficient Mouse Embryos
Total RNA was extracted from individual eyeballs of Tgfb1,
Tgfb2, and Tgfb3 knockout mouse embryos at E18.5 and subjected
to northern hybridization using 1.3% agarose gel electrophoresis
for lumican, keratocan, collagen I, and keratin12 as previously
reported (Kao et al., 1996; Liu et al., 1998; Saika et al., 2000). One
litter was used in each of E18.5 Tgfb1, Tgfb2, and Tgfb3 knockout
mouse embryos.
BrdU Labeling of the Embryos
To label the proliferating cells in individual embryos, BrdU
(Sigma, 120 mg/g body weight) was administered intraperitoneally
to time-mated pregnant females, 2 h later, the animals were killed
and embryos were obtained by Cesarean section. The embryos were
fixed and embedded in paraffin. To detect proliferating cells in
developing corneal stroma, 5 mm paraffin sections were immuno-
© 2001 Elsevier Science. Astained with a monoclonal anti-BrdU antibody [10X diluted in
phosphate-buffered saline (PBS: 0.15 M NaCl, 10 mM PO4 buffer
pH 7.4), Boehringer Mannheim]. Secondary antibody reaction and
color development were performed as described above. The sec-
tions were counterstained with hematoxylin. The number of total
corneal fibroblasts and the number of BrdU-labeled cells were
determined in sections from the central parts of the eyes of
individual heterozygous and homozygous embryos. For this pur-
pose, a perpendicular line to the ocular surface epithelium through
the anterior apex of the developing neural retina was drawn to
distinguish the cornea from sclera stroma on a computer monitor
using ImagePro Plus (Media Cybernetics, Silver Spring, MD, USA).
The number of keratocytes in an area of 500 mm2 at the central
corneal stroma of Tgfb2 null mice was determined to estimate the
cell density in the corneal stroma. The cell on the borderline of the
area examined was counted as 0.5. The data were analyzed by an
unpaired Student’s t-test. A value of p , 0.05 was considered
statistically significant.
In Situ Nick End Labeling of DNA Strand Breaks
To detect programmed cell death in corneal stroma, the TUNEL
method was performed. Deparaffinized sections were digested by 2
mg/ml of proteinase K (Sigma-Aldrich, St. Louis, MO, USA) for 5
min at room temperature. After washes in PBS and distilled water,
tissue sections were incubated with 1X TdT (terminal deoxynucle-
otide transferase) buffer for 2 min (Gibco-BRL, Life Technologies,
Inc., Gaithersburg, MD, USA). Sections were then treated with 1X
TdT buffer containing TdT and biotinylated-dUTP (Boehringer
Mannheim) for 45 min at 37°C. After PBS wash, the sections were
allowed to react with streptoavidine-peroxidase (200X diluted in
PBS, Dako, Carpinteria, CA, USA) for 30 min at 37°C. After
another wash in PBS peroxidase reaction was performed with 3,
39-diaminobenzidine. After counterstaining with methyl green,
sections were embedded in balsam and observed by light micros-
copy. For positive controls, the sections were treated with 10 mg/ml
of DNase I for 10 min and then processed for the TUNEL staining.
RESULTS
Light Microscopy of Corneas during Development
of Mice Lacking TGFb Isoforms
To examine corneal development of Tgfb1, Tgfb2, and
Tgfb3 null mice, time-mated embryos at E12.5, 14, 5, 16.5,
and 18.5 were obtained and subjected to light microscopy as
described in Materials and Methods. No abnormality of eye
development could be identified in Tgfb21/2 mice as com-
pared to their wild type littermates. Eye development is not
disturbed in Tgfb1 and Tgfb3 null mice. The morphology of
eyes from E18.5 Tgfb1 and Tgfb3 null mice is identical to
that of heterozygous Tgfb21/2 mice (Fig. 1K), and to that of
Tgfb11/2, Tgfb31/2, and wild type mice (data not shown),
whereas prominent morphological abnormalities are appar-
ent in the eyes of Tgfb2 null mice as compared to their
heterozygous littermates (as shown in Fig. 1). The absence
of TGFb2 does not disrupt lens growth; however, the
development of neural retina and cornea is severely com-
promised. The neural retina of Tgfb22/2 mice does not
laminate and undergo normal differentiation. A large cell
ll rights reserved.
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numerous blood vessels and numerous hyalocytes can still
be seen at E18.5 (Fig. 1).
At E12.5 many mesenchymal cells presumably derived
FIG. 1. Hematoxylin and Eosin staining of eyes of Tgfb21/2 and
Tgfb22/2 mice during embryonic development. Embryos at various
development stages were fixed in 4% paraformaldehyde and em-
bedded in paraffin. Five micrometers sections were stained with
Hematoxylin and Eosin. The development of Tgfb21/2 mice is
identical to wild type mice. At E12.5 lens placoid already detaches
from the ectoderm, the cornea contains a 2-cell layer epithelium
and a loose stroma. At E14.5 and E15.5, anterior chamber forms and
the cornea consist of three distinct layers, that is, epithelium (2–3
cell layers), stroma and a single cell layered endothelium. Eyelid
begins to grow, but not yet fused. Neural retina undergoes differ-
entiation. Eyelid fuses at E16.5 and pushes cornea backward. The
anterior chamber becomes smaller. The eye grows bigger at E18.5.
The thickness of corneal stroma increases. The eye development of
Tgfb22/2 mice in most parts differs from that of Tgfb21/2 mice. At
all stages examined, the lens never separates from cornea, no
endothelium forms, and the corneal stroma is very thin. A huge cell
mass exists in-between the space of lens and neural retina, and the
neural retina does not undergo normal differentiation. The scale
bar is equal to 500 mm.from neural crest accumulate in the loose stromal matrix
© 2001 Elsevier Science. Aunderneath the corneal epithelium of Tgfb21/2 mice (Figs.
1A and 2A). However, no distinct endothelium can be
discerned at this stage. This observation differs from avian
corneal development in which two waves of neural crest
cell migration occur (Hay, 1980). The mesenchymal cells
from the first wave of neural crest cells form the endothe-
lium prior to the second wave of mesenchymal cells that
form the secondary corneal stroma. At E14.5, a distinct
endothelium can be seen in the cornea of Tgfb21/2 mice and
the lens is separated from the cornea (Figs. 1 and 2). Thus,
an anterior chamber is formed in Tgfb21/2 mice. Around
E15.5–16.5, fusion of the eyelids is complete, which pushes
the cornea backward and causes the anterior chamber to
become smaller. Interestingly, in Tgfb22/2 mice the cornea
does not separate from the lens and the stroma is very thin
as compared to that of Tgfb21/2 and wild type mice. At
higher magnification as shown in Fig. 2, no endothelium
forms in cornea, limbus, and trabecular mesh works of
Tgfb22/2 mice. The central stroma adheres to the lens
capsule. To further elucidate this morphological abnormal-
ity, the corneas of E18.5 mice were subjected to electron
microcopy as described below.
Electron Microscopy of Corneal Stroma and
Endothelium in E18.5 Tgfb2 Knockout
Mouse Embryos
Electron microscopic examination revealed that the epi-
thelial basement membrane is well developed in both
Tgfb21/2 and Tgfb22/2 mice. The corneal epithelium of
Tgfb22/2 mice is morphologically similar to that of Tgfb21/2
mice as examined by electron microscopy. Remnant capil-
laries can be seen between stroma and lens capsule in
Tgfb22/2 mice (data not shown). Figure 3 demonstrates that
the corneal stroma of Tgfb22/2 mice is thinner than that of
Tgfb21/2 mice and has smaller intercellular spacing, indi-
cating decreased ECM accumulation (compare Figs. 3C and
3E to 3A). Figure 3B demonstrates a fine basal lamella-like
structure overlaying the continuous endothelial cell layer
in Tgfb21/2 mice. Junctional complexes can be seen be-
tween the endothelial cells of Tgfb21/2 mice. Figures 3C and
3E demonstrate that in Tgfb22/2 mice the cells at the
posterior stroma of the peripheral region fail to form a
continuous endothelial cell layer. In the central region of
Tgfb22/2 stroma, cells adhere to the lens capsule (Fig. 3D).
No intercellular junctional complex nor basal lamella-like
structure can be found in the posterior region of Tgfb22/2
cornea (Fig. 3D and 3F). Less collagenous matrix accumu-
lation is seen in the extracellular space between stromal
keratocytes of Tgfb22/2 mice as compared to that of
Tgfb21/2 mice. However, higher magnification images re-
veal that the collagen fibrils are similar in size and are
organized in a similar pattern of lamellar sheets (data not
shown).
The abnormal ocular morphology of Tgfb22/2 mice re-
sembles that of Axenfeld-Reiger’s anomaly caused by mu-





423TGFb2 in Corneal Morphogenesis(Kidson et al., 1999). To examine whether FoxC1 may be a
target gene of the TGFb2 signaling pathway, in situ hybrid-
ization with FoxC1 riboprobes was performed. Hybridiza-
tion signals are detected in periocular mesenchyme cells
and cells derived from periocular mesenchyme, that is, iris
stromal cells, corneal endothelial cells of both Tgfb21/1 and
Tgfb22/2 mice, vitreous hyaloid cells of Tgfb22/2 mice, and
conjunctiva epithelial cells of both Tgfb21/1 and Tgfb22/2
mice (data not shown). Thus, the expression pattern of
FoxC1 is basically identical between Tgfb21/1 and Tgfb22/2
mice and similar to data reported by other investigators
(Kidson et al., 1999; Pressman et al., 2000), except the latter
do not have an endothelial cell layer and have an underde-
veloped iris stroma.
Cell Proliferation and Cell Death in Corneal
Stroma of Tgfb2 Null Mice
It is hypothesized that thinner stroma found in Tgfb22/2
FIG. 2. HE staining of the eye of E14.5 Tgfb21/2 and Tgfb22/2 mic
stained and examined at 40X magnification (objective). Panels A, B
no distinct endothelium can be recognized. The endothelium form
Tgfb22/2 mice, no endothelium forms in any of the developmental
Tgfb21/2 mice. The bar is equal to 50 mm.mice may result from fewer keratocytes present in the
© 2001 Elsevier Science. Atissue, which are responsible for the synthesis of stromal
ECM. Thus, the number of keratocytes in the corneal
stroma of Tgfb22/2 and Tgfb21/2 mice was determined.
Figure 4A demonstrates that numbers of keratocytes are
significantly fewer in the stroma of Tgfb22/2 mice from
E12.5 through E18.5 as compared to Tgfb21/2 mice. The
total number of keratocytes in stroma of Tgfb21/2 mice
levels off between E16.5 and E18.5. In contrast, keratocyte
number steadily increases in Tgfb22/2 mice from E12.5
through E18.5. The cell densities in 500 mm2 of central
corneal stroma of E18.5 embryos are 9.25 6 1.71 (mean 6
SD) in Tgfb21/2 mice and 13.25 6 2.5 in Tgfb22/2 mice (p ,
0.005 by unpaired Student’s t-test). This result is consistent
with the thinner corneas with less accumulation of ECM
found in Tgfb22/2 mice as compared to that from wild type
and Tgfb21/2 mice. The thinner cornea causes the cell
density in Tgfb22/2 mice to be higher, even though the total
number of cells is less and their growth phase is extended.
e micrometer sections of E12.6 through E18.5 embryos were H&E
C: Tgfb21/2 mice at E12.5, E14.5, and E18.5, respectively, at E12.5
ween E13.5 and E14.5, and the size of corneal stroma increases. In
es examined. The cornea remains much thinner in comparison toe. FivTo examine whether the decreased number of kerato-
ll rights reserved.
424 Saika et al.FIG. 3. Electron micrographs of corneas from Tgfb21/2 and Tgfb22/2 mice. Corneas from E18.5 mouse embryos were fixed in glutaraldehyde and
subjected to electron microscopy. Panels A and B, cornea of a Tgfb21/2 mouse. Panel A, a distinctive endothelium underlies the posterior cornea
stroma. Panel B, higher magnification of Panel B indicates the existence of junctional complexes between two endothelial cells (arrows) and basal
lamellae (arrow heads). Panels C and D, micrographs of the central cornea of Tgfb22/2 mice. Fibroblasts adhere to the lens capsule and no
junctional complex can be seen. Panels E and F, micrographs from the peripheral cornea of a Tgfb22/2 mouse. No endothelium underlies the
stroma and no junctional complex can be discerned between adjacent fibroblasts. Bar is equal to 5 mm in Panels A, C, and E; 0.5 mm in Panel B,
D, and F.
© 2001 Elsevier Science. All rights reserved.
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425TGFb2 in Corneal Morphogenesiscytes in Tgfb22/2 mice might result from a decreased rate of
cell proliferation, the number of cells undergoing DNA
synthesis was determined by BrdU incorporation. Figure 4B
and 4C show that the number of BrdU-labeled cells in
stroma of Tgfb21/2 mice decreases at later developmental
stages, for example, E15.5 and thereafter. In Tgfb22/2 mice
the number of BrdU-labeled cells also decreases at later
developmental stages (E14.5 through E18.5); however, it
remains higher than that from Tgfb21/2 mice (Figs. 4B and
4D). This observation is consistent with the steady increase
of keratocytes seen in Tgfb22/2 mice. Therefore, the lack of
TGFb2 does not impair the proliferative capacity of kerato-
cytes.
To examine whether apoptosis may account for the
decrease of keratocytes in Tgfb22/2 mice, TUNEL assay was
used to detect cells undergoing apoptosis in several tissues
including the nervous system of Tgfb21/2 and Tgfb22/2
mice. Surprisingly, no TUNEL-positive cells are detected in
the corneal stroma and endothelium and in crystalline lens
and vitreous through these embryonic stages in both
Tgfb21/2 and Tgfb22/2 mice (data not shown). TUNEL
positive cells are detected in brain control tissue (data not
shown). The observations indicate that apoptosis may not
play a major role in modulating cell numbers in the cornea
during development.
Down Regulation of ECM Synthesis by Keratocytes
of Tgfb2 Null Mice
It has been demonstrated that TGFbs modulate the
metabolism of ECM components and play a pivotal role in
the maintenance of the homeostasis of interstitial connec-
tive tissues in physiological and pathological conditions
(Hay, 1995; Imai et al., 1997; Jimenez et al., 1996; Zhang et
al., 2000). Therefore, the expression of ECM components,
for example, collagen I, lumican, keratocan was examined
by in situ and northern hybridization, and by immunohis-
tochemistry to examine whether the absence of TGFb2
might alter the deposition of ECM in stroma. Figure 5A
TABLE 1
Summary of In Situ Hybridization and Immunohistochemical Exa
Embryonic days 12.5 14.5
Genotype 1/2 2/2 1/2 2/2
Lum mRNA 2 2 11 2
Lumican 2 2 1 2
Ktcn mRNA 2 2 11 2
Collagen I 2 2 1 2
Krt1.12 mRNA 2 2 1 2
Keratin 12 2 2 2 2
Note. Proteins or mRNAs were detected by immunohistochem
positive; 111, strongly positive; 2, negative.demonstrates that the levels of mRNAs of ECM compo-
© 2001 Elsevier Science. Anents, that is, collagen I, keratocan, lumican, osteoglycin,
are significantly lower in corneas of E18.5 Tgfb22/2 mice
than Tgfb21/2 mice, in particular the hybridization signals
for keratocan is almost nil.
In situ hybridization with riboprobes confirms the de-
creased expression of collagen I, lumican, keratocan in
corneas of Tgfb22/2 mice. We previously have demonstrated
that in adult mouse the synthesis of keratocan, a member of
small leucine repeat proteoglycan, is limited to corneal
keratocytes (Liu et al., 1998). Thus, keratocan can be
considered a corneal keratocyte differentiation marker. To
further examine whether the absence of TGFb2 may change
keratocyte differentiation, in situ hybridization for kerato-
can was performed with embryos at E12.5 through E18.5. At
E12.5 no hybridization signal for keratocan mRNA can be
detected in corneal keratocytes of both Tgfb21/2 and
Tgfb22/2 mice. The hybridization signal increases in stroma
of Tgfb21/2 mice at later gestational ages, whereas little
hybridization signal is detected in Tgfb22/2 mice at all
developmental stages (Table 1). At E16.5, a strong hybrid-
ization signal for keratocan mRNA is detected in corneal
keratocytes of Tgfb21/2 mouse embryos, but it is very weak
in Tgfb22/2 embryos (Figs. 5B and 5C).
The in situ hybridization signal for collagen I and lumi-
can is weak, albeit readily detectable in Tgfb22/2 embryos
(data not shown). The observations were confirmed by
immunohistochemistry in corneas of E18.5 embryos with
antibodies against lumican and collagen I. Figures 5D and
5E demonstrate that the immune reactivity by anti-
lumican antibodies in Tgfb22/2 stroma is much less than in
Tgfb21/2 stroma. Similar results are obtained with anti-type
I collagen (Figs. 5F and 5G, and Table 1). No difference for
the expression of collagen I and lumican mRNAs is found in
heterozygous and homozygous Tgfb1 and Tgfb3 knockout
mouse embryos (data not shown). Expression patterns of
each ECM component are summarized in Table 1. The
observations are consistent with an overall down regulation
of ECM synthesis in Tgfb22/2 mice, rather than changes of
tions in TGFb2-Deficient Mouse Embryos
15.5 16.5 18.5
1/2 2/2 1/2 2/2 1/2 2/2
11 2 11 1 1 1
1 2 11 2 111 1
11 2 111 1 1 2
1 2 11 2 111 1
11 11 11 11 11 11
1 1 11 11 11 11
or in situ hybridization, respectively. 1, weakly positive; 11,minakeratocyte differentiation.
ll rights reserved.
FIG. 4. Total cell number and BrdU-labeled cells in corneas of Tgfb21/2 and Tgfb22/2 mice. Timed-pregnant female mice were injected
with BrdU (120 mg/g) 2 h prior to sacrifice. The embryos were obtained by Caesarian section and processed for immunohistochemistry with
anti-BrdU antibodies. The total cell number and BrdU-labeled cells in stroma per cornea section was counted under a light microscope as
described in the Materials and Methods section. Panel A, total cell number in stroma per cornea section; Panel B, number of BrdU-labeled
cells in stroma per cornea section; Panel C & D, representative micrographs of BrdU-labeled corneas from E18.5 Tgfb21/2 and Tgfb22/2 mice,
respectively. The number of cells per cornea section is the average of three sections of each individual cornea. Number in parenthesis was
the number of corneas examined for the embryonic stage indicated. Bar is 200 mm.
FIG. 5. Expression of ECM components: collagen I, lumican, keratocan and mimecan mRNAs. Panel A, northern hybridization: Total
RNA isolated from whole eyes of E18.5 Tgfb21/2 and Tgfb22/2 mice were subjected to Northern hybridization with 32P-labeled cDNAs for
mRNAs of collagen a1(I) chain (Col1a1, 5.5 and 4.7 kb), lumican (Lum, 2.1 kb), keratocan (Ktcn, 2.2 kb), osteoglycin (Ogn, 2.4 kb) and
glyceraldehyde phosphate dehydrogenase (Gapdh, 1.2 kb). 1/1, wild type mouse; 1/2, Tgfb21/2 mouse; 2/2, Tgfb22/2 mouse. Gapdh is
used as a reference for the amount of total RNAs in the specimens. The expression of these ECM components is down regulated in corneas
of Tgfb22/2 mice. Panels B and C, in situ hybridization of E16.5 corneas for keratocan. Panels D and E, immunostaining with anti-lumican
antibodies of E18.5 corneas. Panels F and G, immunostaining with anti-collagen I antibodies. Antibody staining begins to be detected in
stroma of E15.5 Tgfb21/2 mice and becomes stronger at E18.5. Very weak immune activity is detected in the stroma of Tgfb22/2 mice at all
developmental stages. Anti-collagen I antibodies weakly label the corneas of Tgfb21/2, but not Tgfb22/2 mice at E12.5 (data not shown).
1/2Substantial immune activity begins to be detected in the stroma of E15.5 Tgfb2 mice and becomes stronger at E18.5. Very weak immune
activity is detected in the stroma of E18.5 Tgfb22/2 mice.
427TGFb2 in Corneal MorphogenesisFIG. 6. Expression of Differentiation Markers by Corneal Epithelial and Endothelial Cells: keratin 12, collagen IV, TBDN and N-cadherin.
Panels A and B, immunostaining with rabbit anti-keratin 12 antibodies. Positive immune reactions are seen in corneal epithelial cells of
Tgfb21/2 and Tgfb22/2 embryos at E18.5. Panels C and D, immunostaining with rabbit anti-collage IV antibodies. Epithelium and
keratocytes of both E18.5 Tgfb21/2 and Tgfb22/2 mice yield positive hybridization signals using an antisense collagen IV riboprobe. The
expression patterns of collagen IV are similar between Tgfb21/2 and Tgfb22/2 mice, except the Tgfb22/2 does not have endothelium as seen
in panel C. The anti-collagen IV antibodies label the epithelium basement membrane and stroma of both E18.5 Tgfb21/2 and Tgfb22/2 mice.
The endothelium of E18.5 Tgfb21/2 mice also reacts to the antibodies, but there is no endothelium in Tgfb22/2 mice. Panels E, F, I, and J,
immunostaining with chicken anti-TBDN. Adult corneal endothelium also expresses TBDN-1 as indicated (E) while adjacent sections
stained with preimmune IgY show no staining (F). As indicated in (J; Tgfb22/2) and (I; Tgfb21/2), no staining for TBDN-1 acetyltransferase
protein is observed in cells corresponding to the equivalent of the inner surface of the corneal stroma in Tgfb22/2 embryos, while corneal
endothelial cells in E16.5 wild type and Tgfb21/2 embryonic corneas express high levels of TBDN-1. Panels G, H, K, and L, immunostaining
with monoclonal anti-N-cadherin antibodies. Adult corneal endothelium does not express N-cadherin as indicated (G), while peripheral
lens fibers in the same sections express N-cadherin (H). Similarly, as indicated in (L; Tgfb22/2) and (K; Tgfb21/2), no staining for N-cadherin
protein is observed in cells corresponding to the equivalent of the inner surface of the corneal stroma in Tgfb22/2 embryos, while corneal
1/2endothelial cells in E16.5 wild type and Tgfb2 embryonic corneas express high levels of N-cadherin. Bars are 100 mm in panels A-D and
50 mm E-L. symbols: arrow head, corneal epithelium; black arrow, corneal endothelium; blue arrow, lens epithelium.
© 2001 Elsevier Science. All rights reserved.
428 Saika et al.Expression of Differentiation Markers, for
Example, Keratin 12, Collagen IV, TBDN-1,
and N-cadherin by Corneal Epithelial and
Endothelial Cells of Tgfb22/2 Mice
One possible explanation for the abnormal morphology of
Tgfb22/2 corneas is that the absence of TGFb2 may alter the
differentiation of various corneal cell types. Thus, in situ
hybridization and immunohistochemistry for keratin 12
(epithelium), and collagen IV, TBDN-1 (epithelial and en-
dothelial cells) and N-cadherin (endothelial cells) were
employed.
Expression of Keratin 12 in Corneal Epithelial Cells
The expression patterns of keratin 12 protein and mRNA
were examined by immunohistochemistry and by in situ and
northern hybridization. Anti-keratin 12 antibodies positively
label the corneal epithelial cells of E16.5 and E18.5 Tgfb21/2
and Tgfb22/2 mice, but not those of E14.5 mice (Figs. 6A and
6B, Table 1). Very weak immune reactivity is detected in
E15.5 Tgfb21/2 and Tgfb22/2 mice. The expression of keratin
12 was confirmed by in situ hybridization which detects
sporadic expression of keratin 12 mRNA in corneal epithelial
cells of E15.5 Tgfb22/2 and Tgfb21/2 mice. Thereafter, hybrid-
ization signals are detected in all corneal epithelial cells. No
difference in the hybridization signal for keratin 12 mRNA is
observed among littermates of heterozygous and homozygous
knockout mice in all embryonic stages examined (data not
shown).
Collagen IV Expression
In adult cornea, collagen IV that is primarily synthesized
by epithelial and endothelial cells can be used as a differ-
entiation marker for both cell types. The expression of type
IV collagen a1 chain (Col4A1) was examined by in situ
hybridization and immunohistochemistry. The expression
of collagen IV is detected in corneas by immunostaining
with anti-collagen IV antibodies. In both Tgfb21/2 and
Tgfb22/2 mice corneal epithelial basement membrane is
labeled by the antibodies, and weak immunoreactivity for
type IV collagen is also seen in the corneal stroma. The
endothelial basement membrane of Tgfb21/2 mice is la-
beled, but not in Tgfb22/2 mice as shown in Figs. 6C and 6D,
respectively. Similar results are obtained by in situ hybrid-
ization (data not shown). Predictably, there is no difference
in expression patterns of collagen IV in the corneas of
heterozygous and homozygous littermates of TGFb1- and
b3-deficient mice at E18.5 as determined by in situ hybrid-
ization and immunostaining (data not shown).
TBDN-1 and N-cadherin Expression
TBDN-1 is a recently isolated novel acetyltransferase asso-
ciated with blood vessel development (Gendron et al., 2000).
TBDN-1 protein is expressed in corneal endothelium in nor-
mal adult mouse eyes (Fig. 6E, F, nonimmune IgY control).
© 2001 Elsevier Science. AHowever, during development TBDN-1 is also expressed
throughout the eye but at varying levels of expression in
different tissues in the eye. TBDN-1 is expressed at interme-
diate levels in the corneal stroma and lens as shown in Figs. 6I
and 6-J. TBDN-1 is expressed highly by epithelial cells and
endothelial cells in wild type and Tgfb21/2 corneas. In
Tgfb22/2 eyes, TBDN-1 is expressed at lower levels through-
out the eye than in wild type and Tgfb21/2 eyes. The absence
of a cell layer between the lens epithelium and the corneal
stroma expressing high levels of TBDN-1 in Tgfb22/2 embry-
onic corneas is consistent with the absence of corneal endo-
thelial cells in Tgfb22/2 mice.
N-cadherin is expressed by developing mouse corneal endo-
thelial cells and is thus a corneal endothelial marker (Reneker
et al., 2000). As shown in Figs. 6G and 6H, we find that adult
mouse corneal endothelium does not express N-cadherin (Fig.
6G), while adult mouse peripheral lens fibers in the same
sections express N-cadherin in a pattern consistent with
previous reports of N-cadherin expression in peripheral lens
fibers in chick lens (Leong et al., 2000). Thus the peripheral
lens fiber expression of N-cadherin in adult mouse eyes also
serves as a positive internal control for N-cadherin expression.
While Tgfb21/2 corneal endothelial cells express high levels of
N-cadherin, as previously described, the absence of a similar
cell layer expressing high levels of N-cadherin between the
lens epithelium and the corneal stroma in Tgfb22/2 embryonic
corneas is also consistent with the absence of corneal endo-
thelial cells in Tgfb22/2 mice.
Immunostaining with Anti-macrophage
Monoclonal Antibody F4/80
It was previously suggested that macrophages play impor-
tant roles in removal of the hyaline cell mass of vitreous
during mouse eye development (Lang and Bishop, 1993).
Immunostaining with the monoclonal antibody F4/80 that
recognizes macrophages was performed to examine whether a
macrophage deficiency may cause the accumulation of hya-
line cell mass in vitreous of Tgfb22/2 mice. Figure 7 demon-
strates that no macrophage can be identified in the eyes of
E13.5 Tgfb22/2 mice. Similar results are obtained for E15.5
Tgfb22/2 mice (data not shown). However, F4/80 positively
stains macrophages in the vitreous body and between the
cornea and lens of Tgfb21/2 mice at E13.5-E15.5. It should be
mentioned that the presence of macrophages is not detected in
all sections examined. Therefore, Table 2 summarizes the
incidence of macrophage appearance in ocular tissues in
Tgfb22/2, Tgfb21/1, and Tgfb21/2 mice. The data indicate that
very few macrophages invade the ocular tissues of Tgfb22/2
mice at E12.5 through E15.5, whereas macrophages can be
detected in ocular tissues of wild type and Tgfb21/2 mice at
similar developmental stages.
DISCUSSION
Three TGFb isoforms (b1, b2, and b3) are known in mam-
mals (Massague, 1990). TGFbs are expressed by various tis-
ll rights reserved.
429TGFb2 in Corneal Morphogenesissues, but their spatial and temporal expression patterns and
their regulation of target genes differs considerably, though
not entirely, during embryonic development (Moses and Serra,
1996; Pelton et al., 1991). Therefore, individual TGFbs may
have specific roles in modulating specific tissue morphogen-
esis events during embryonic development, as exemplified by
different phenotypes among Tgfb2/2 mice. For example, Tgfb1
and Tgfb3 null mice are characterized by systemic lympho-
cytic inflammatory disease and cleft palate, respectively
(Proetzel et al., 1995), without abnormality in ocular morpho-
genesis as shown here. In addition, the loss of TGFb2 leads to
multiple developmental defects that are nonoverlapping with
Tgfb1 and Tgfb3 knockout phenotypes, including a very thin
corneal stroma (Sanford et al., 1997). In the present studies, we
have further characterized the corneal morphogenesis of
Tgfb2 null mice. Relative to Tgfb21/2 eyes Tgfb2 null eyes
display fewer keratocytes in a thin corneal stroma. In addition,
the expression of ECM components is greatly diminished, and
there is a fusion of cornea and lens and a failure of endothe-
lium formation and accumulation of hyaline cells in vitreous.
However, they exhibit normal corneal epithelial differentia-
tion. This phenotype we term a Peters’-like anomaly because
it has similarities to Peters’ anomaly in human.
Tgfb22/2 mice have thin corneal stromas with fewer
keratocytes than normal. This is due to diminished accu-
mulation of the ECM components, that is, collagen I,
lumican, and keratocan, rather than to impaired prolifera-
tive capability or enhanced apoptosis of keratocytes. The
smaller volume of stroma resulting from decreased ECM
may become a physical limiting factor leading to an inabil-
ity to accommodate the rapid increase in keratocyte result-
ing from neural crest cell invasion and/or keratocyte pro-
liferation during embryonic development. In addition,
recent evidence indicates that many ECM proteins have
additional biological functions other than serving as struc-
TABLE 2
F4/80 Positive Cells in Tgfb2 Knockout Mice
Embryonic Days/Genotypes # of sections containing F4/801
Cells/Total Sections Examined
1/1 and 1/2 2/2
E12.5 6a/119 (6) 0/94 (5)
E13.5 22b/130 (3) 1c/63 (4)
E14.5 21d/93 (13) 1e/66 (5)
E15.5 18f/80 (7) 6g/109 (4)
Note. Positively labeled cells are found in posterior region
(vitreous), occasionally macrophages can be found in anterior
region between cornea and lens. All sections containing macro-
phages in anterior also have macrophage in posterior. Numbers in
parentheses are the number of eyes analyzed.
a Number of macrophages found 1–5; bNumber of macrophages
1–8; cNumber of macrophages found 8; dNumber of macrophages
1–5; eNumber of macrophages 1; fNumber of macrophages 1–15;
gNumber of macrophages; 3–10 (all in posterior region).tural components, for example, tumor suppression, cell
© 2001 Elsevier Science. Amigration, etc. (Csordas et al., 2000). We have recently
demonstrated that lumican may facilitate epithelial cell
migration during corneal wound healing (Saika et al., 2000).
It has also been known that neural crest cell migration on
ECM is mediated via integrin receptors (De Arcangelis and
Georges-Labouesse, 2000). In ovo injection of RGD-
containing peptides perturbs normal neural crest cell mi-
gration in avian embryos (Boucaut et al., 1984). Thus it is
plausible that the decreased accumulation of ECM compo-
nents containing RGD motifs, for example, collagen I,
lumican and keratocan, may compromise neural crest cell
migration in Tgfb22/2 mice during development.
TGFb2 may also play an important role in mediating the
differentiation of neural crest-derived periocular mesenchy-
mal cells. During embryonic development the mesenchy-
mal cells of neural crest origin invade the primary stroma at
;E12.5, and an endothelium with junctional complexes
(Kidson et al., 1999) subsequently forms through a
mesenchymal-endothelial transformation. InTgfb22/2 em-
bryos the cells lining the inner surface of the corneal stroma
do not transform to endothelium and fail to form intercel-
lular junctional complexes. Instead, they maintain a
fibroblast-like morphology and do not express TBDN-1
and N-cadherin, which is consistent with the absence of
corneal endothelium. TGFbs often have been implicated
in cell transdifferentiation (Roberts and Sporn, 1990). In
vitro, TGFb can induce epithelial-mesenchymal transfor-
mation in mammary, lung, and kidney epithelia (Mietti-
nen et al., 1994). In vivo, Mu¨llerian inhibitory factor, a
member of the super family of TGFb genes, induces
epithelial-mesenchymal transformation of the mamma-
lian male Mu¨llerian duct (Behringer et al., 1994; Trelstad
et al., 1982). TGFb2 has been strongly implicated in the
transformation of cardiac endothelium into cushion mes-
enchyme during the formation of endocardial cushion
tissue (Boyer et al., 1999; Brown et al., 1999; Sanford et
al., 1997). The absence of TGFb3 leads to defective
palatal fusion (Kaartinen et al., 1995; Proetzel et al.,
1995), a process involving epithelial-mesenchymal trans-
formation (Hay, 1995), cell migration (Carette and Fergu-
son, 1992) and cell death (Mori et al., 1994). Recent
evidence suggests that the role of TGFb3 in palatal fusion
is to induce epithelial cell migration into nasal and oral
epithelium, as well as apoptosis, but not transdifferentia-
tion into mesenchyme (Martinez-Alvarez et al., 2000).
The latter study demonstrates that even though the
absence of a gene can disrupt a developmental event
involving a transdifferentiation process, that event may
require other processes, one or more of which may be
essential. Consequently, we can not yet state definitively
that TGFb2 is directly required for the mesenchymal-
endothelial transformation that occurs in corneal devel-
opment, or whether it is required secondarily through
some other requirement for the transformation, such as
proper stromal matrix composition.
It is well known that corneal endothelium has a vital
function of pumping water out of the stroma for the
ll rights reserved.
430 Saika et al.maintenance of proper corneal hydration. The water out-
flow from cornea to anterior chamber may contribute to the
buildup of intraocular pressure. The absence of corneal
endothelium in Tgfb22/2 mice may inhibit water flow and
lead to subsequent failure to generate adequate intraocular
pressure or signals for the separation of lens from cornea.
The failure of the lens to separate from the cornea and for
the anterior chamber to form is a phenotype that is similar
to that in mice with mutations in, and/or ablation of,
FoxC1 and Pitx2 which have been linked to the Axenfeld-
Reiger’s anomaly of FKHL7 mutations in human (Kidson et
al., 1999; Lu et al., 1999). The cellular and molecular
mechanisms of Axenfeld-Reiger’s anomaly caused by mu-
tations of FKHL7 and ablation of FoxC1 and Pitx2 remain
unknown. It is of interest to note that the expression
pattern of FoxC1 is not altered in Tgfb22/2 mice (data not
shown), suggesting that FoxC1 is not among the target
genes of the TGFb2 signaling pathway in the eye. However,
FoxC1 and TGFb2 may share a common down stream
pathway in corneal endothelial differentiation. It is of
FIG. 7. Immunostaining with rat monoclonal antibody F4/80.
Paraffin sections of E13.5 mice were incubated with monoclonal
rat F4/80 antibody against mouse macrophages. Panels A, B, and C,
Tgfb21/2 mice; panels D, E, and F, Tgfb22/2 mice. B and E anterior;
C and F, posterior. The bar in A and D is 200 mm; bar in B, C, E, and
F is 50 mm. No positive-labeled cells are identified in eyes of
Tgfb22/2 mice.interest to note that stroma of FoxC1 null mice have
© 2001 Elsevier Science. Anormal thickness, indicating that the FoxC1 protein does
not modulate ECM synthesis (Kidson et al., 1999).
Immunohistochemistry and in situ hybridization showed
that type IV collagen protein production by epithelial and
endothelial cells as well as by keratocytes is not perturbed
in the absence of TGFb2. However, the inner stromal cells
of Tgfb22/2 mice express collagen IV as do those of Tgfb21/1
and Tgfb21/2 mice, but fail to synthesize the Descemet’s
membrane, the basement membrane underlining the endo-
thelium. These observations also suggest that the regula-
tion of type IV collagen expression differs from that of type
I collagen in embryonic corneal cells in that it is down
regulated in the absence of TGFb2. It has been a common
belief that keratocytes do not synthesize collagen IV under
normal physiological conditions, for example, corneal mor-
phogenesis during development and homeostasis in adults
(Ishizaki et al., 1993a; Ishizaki et al., 1997). The significance of
collagen IV synthesis by keratocytes during mouse embryonic
development remains elusive. This observation is consistent
with the notion that corneal morphogenesis in mouse differs
from that in other species, for example, avian, rabbits, and
humans. However, Linsenmayer and co-workers have demon-
strated the presence of string collagen IV in avian corneal
stroma during development, although the cell type respon-
sible for its synthesis is not known (Fitch et al., 1991). Under
pathological conditions such as wound healing synthesis of
collagen IV by stromal cells has been recognized (Ishizaki et
al., 1997). However, these stromal cells express a-smooth
muscle actin and are more characteristic of a myofibroblast
phenotype (Ishizaki et al., 1993b).
Our studies also clarify the purported role of TGFbs on
corneal epithelial cell differentiation in vivo. TGFbs have
been shown previously to inhibit epithelial cell prolifera-
tion in vitro, in addition to being stimulatory to many
mesoderm-derived cell types (Roberts and Sporn, 1990).
However, the present study shows that the loss of one
TGFb family member does not induce epithelial cell hyper-
proliferation or alter the differentiation of corneal epithelial
cells. Thus, none of the TGFbs is essential for corneal-type
epithelial differentiation.
Immunostaining with rat monoclonal F4/80 anti-mouse
macrophage antibodies demonstrate impaired macrophage
invasion into the ocular tissues of Tgfb22/2 mice. Hay
previously observed the presence of macrophages in devel-
oping avian corneas and suggested that macrophages might
play an important role in clearing tissue debris when the
lens separates from surface ectoderm (Hay and Revel, 1969).
However, the number of macrophages present in anterior
segments of embryonic eyes is small and may not be a
major factor responsible for the separation of lens from
cornea during eye development. Nevertheless, the signifi-
cance of macrophages in ocular morphogenesis has been
previously demonstrated in that macrophages contribute to
the removal of vitreous hyaline cells during development
via induction of apoptosis (Lang and Bishop, 1993). This
observation is consistent with the chemotactic activity of
TGFb2 for macrophages (Allen et al., 1990). It has been
ll rights reserved.
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ways can modulate macrophage invasion into injured tis-
sues. For example, the facilitated healing of epithelial
wounds in Smad3 null mice is associated with delayed
invasion of macrophages into the wounds (Ashcroft et al.,
1999). It should be noted that TUNEL staining fails to
detect the presence of apoptotic cells in the vitreous of wild
type, Tgfb21/2 and Tgfb22/2 mice. This observation can be
in part explained by the fact that the presence of macro-
phages is only detected in a fraction of tissue sections of
wild type and Tgfb21/2 mice, though hardly in Tgfb22/2
mice. It is also possible that macrophages may contribute to
the removal of hyaline cells in vitreous via another mecha-
nism, for example, phagocytosis. Other studies are needed
to examine the mechanism of removal of vitreous hyaline
cells during development.
It is noteworthy that the fusion of lens to cornea is a
characteristic of many mutant mouse lines defective in the
transcription factor genes FoxC1 and Pitx2 which are linked
to Axenfeld-Reiger’s anomaly (Kidson et al., 1999; Lu et al.,
1999). Recently, Reneker et al. reported that overexpression
of TGF-a and EGF under the control of an aA-crystalline
promoter leads to a phenotype resembling human Peters’
anomaly (Reneker et al., 1995; Reneker et al., 2000). Simi-
larly, in Tgfb2 null mice there is an absence of endothelium
and the fusion of lens to cornea. However, Tgfb2 null mice
also have a thin corneal stroma and accumulation of hya-
line cells in vitreous that are not found in other mouse lines
associated with mal-development of anterior ocular tissues.
Therefore, Tgfb22/2 mice have a “Peters’-like” anomaly
instead of an Axenfeld-Reiger’s and Peter’s anomaly.
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